Effects of dynamic neuromuscular stabilization exercises on chronic low back pain

Effect of Dynamic Neuromuscular Stabilization exercises on pain, functional tests scores, respiratory function, and quality of life in individuals with chronic non-specific low back pain

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240107060646N1

Enrollment

Registered

2024-04-20

Start date

2023-04-03

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-specific chronic low back pain.

Interventions

Intervention 1: Intervention group: Exercise group. Intervention 2: Control group: Control group.

Eligibility

Sex/Gender

All

Age

30 Years to 50 Years

Inclusion criteria

Inclusion criteria: Having a minimum of three months of non-specific chronic low back pain The ability to sit, stand, and walk without using assistive devices Not engaging in regular exercise

Exclusion criteria

Exclusion criteria: Having any specific pathology such as disc protrusion, spinal injury or surgery history, neurological disorders, tumors, osteoarthritis, and rheumatoid arthritis diagnosed by a specialist physician Being diagnosed with any medical condition that restricts physical activity by a physician Experiencing unbearable pain and inability to perform exercises Potential lung tissue damage in case of COVID-19 infection Absenteeism of more than one-third of exercise sessions irregularly or absenteeism of three consecutive sessions Lack of willingness to continue participation in the study

Design outcomes

Primary

Measure	Time frame
Pain is measured using the Visual Analog Scale (VAS). Functional disability is assessed using the Oswestry Disability Index questionnaire. Motor function is measured through Functional Movement Screen (FMS) tests. Spirometry is used to evaluate respiratory performance (FVC, FEV1, and FEV1/FVC). The SF-36 Quality of Life questionnaire is employed for assessing the quality of life. Timepoint: At the beginning of the study (prior to intervention), 8 weeks after the intervention (posttest), and after 2 months of detraining following the posttest. Method of measurement: Pain is measured using the Visual Analog Scale. Functional disability is assessed using the Oswestry Disability Index questionnaire. Motor function is measured through Functional Movement Screen tests. Spirometry is used to evaluate respiratory performance (forced vital capacity, forced expiratory volume in the first second, and the ratio of forced expiratory volume in the first second to forced vital capacity). The Short Form 36-item questionnaire is employed for assessing the quality of life.	—

Measure

Time frame

Pain is measured using the Visual Analog Scale (VAS). Functional disability is assessed using the Oswestry Disability Index questionnaire. Motor function is measured through Functional Movement Screen (FMS) tests. Spirometry is used to evaluate respiratory performance (FVC, FEV1, and FEV1/FVC). The SF-36 Quality of Life questionnaire is employed for assessing the quality of life. Timepoint: At the beginning of the study (prior to intervention), 8 weeks after the intervention (posttest), and after 2 months of detraining following the posttest. Method of measurement: Pain is measured using the Visual Analog Scale. Functional disability is assessed using the Oswestry Disability Index questionnaire. Motor function is measured through Functional Movement Screen tests. Spirometry is used to evaluate respiratory performance (forced vital capacity, forced expiratory volume in the first second, and the ratio of forced expiratory volume in the first second to forced vital capacity). The Short Form 36-item questionnaire is employed for assessing the quality of life.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Mahdavinejad

University of Isfahan

r.mahdavinejad@spr.ui.ac.ir+98 31 3793 2128

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 6, 2026